Introduction
Secretory leukoprotease inhibitor (SLPI), a 12-kD nonglycosylated serine antiprotease, helps to protect the epithelial surface of the airways from the destructive capacity of neutrophil elastase. Based on the recognition that SLPI levels can increase in the presence of airway inflammation, we hypothesized that inflammatory stimuli should modulate the expression of the SLPI gene in airway epithelial cells. To evaluate this, the modulation of SLPI gene expression with various inflammatory stimuli was evaluated in the HS-24 human bronchial epithelial cell line. After preliminary studies showed that several inflammatory mediators enhanced SLPI messenger RNA (mRNA) levels, PMA was used as a model inflammatory stimulus. PMA significantly increased the level of 0.7-kb SLPI mRNA transcripts in HS-24 cells in a dose-and time-dependent fashion and increased the amount of SLPI protein in the culture supernatant. Nuclear run-on analyses showed that the SLPI gene transcription rate increased approximately twofold after PMA stimulation. Transfection studies using fusion genes composed of fragments of up to 1.2 kb of the 5' flanking sequence of the SLPI gene and a luciferase reporter gene demonstrated potent promoter activity in the 131-bp segment (-115 to +16 relative to the transcription start site), and all longer segments up to 1.2 kb, whereas smaller segments showed low promoter activity. An 18-bp element (-98 to -115), in a region with homology to PMA-responsive regions in the Moloney murine leukemia virus enhancer and the 1L-8 gene, was shown to be of importance in the level of transcription of the SLPI gene. However, this element was not responsible for the upregulation of SLPI gene expression by PMA. Evaluation of HS-24 cells in the presence of actinomycin D demonstrated that SLPI mRNA transcripts were very stable and became more so in the presence of PMA. Thus, SLPI gene expression in airway epithelial cells can be upregulated by an inflammatory stimulus, and this modulation is regulated at both the transcriptional and posttranscriptional levels. These mechanisms of SLPI upregulation likely play a role in defending the epithelial surface in the local milieu of inflammatory lung disease. (J. Clin. Invest. 1994 . 94:368-375.) Key words: protease inhibitor * transcription * 5' flanking region * neutrophil elastase * mRNA Secretory leukoprotease inhibitor (SLPI),' a 12-kD nonglycosylated serine antiprotease, is found in fluids lining mucosal surfaces, including those of the respiratory tract (1) (2) (3) (4) . SLPI inhibits several serine proteases, but with an association rate constant for neutrophil elastase (NE) of -10 M-s-1 and the ability to inhibit proteolysis at the neutrophil-substrate interface, the principal physiologic function for SLPI is likely to be protection of local epithelial surfaces against NE (4-7). In the human lung, immunohistochemical studies have demonstrated SLPI in serous cells of submucosal tracheal and bronchial glands and in nonciliated cells of the bronchial and bronchiolar epithelium (2, 3, 8) . Evaluation of fluid lining the airway epithelium of the human lung has demonstrated that SLPI provides substantial protection to the large airway epithelium of the human lung against NE (4, 9, 10) .
Based on the knowledge of the role of SLPI in protecting the epithelial surface of the large airways, the present study focuses on evaluating whether the SLPI gene can be upregulated by inflammatory stimuli. There are several indirect reasons to believe that this may be the case. First, the sequence of the 5' flanking region of the SLPI gene contains promoter elements observed in most regulated genes, such as CAAT and TATA boxes, and putative binding sites for the nuclear transcription factors AP-1 and AP-2, binding motifs known to be responsive to inflammatory stimuli (11) (12) (13) (14) . Second, there is evidence in humans that SLPI levels increase in inflammatory states. For example, the levels of SLPI are increased in the serum of adults with pneumonia (5, 15, 16) and in the respiratory epithelial lining fluid of neonates with pneumonia (17) . Finally, SLPI is in the class of antiproteases that inhibit serine proteases. The other major member of this class in humans is al-antitrypsin (alAT), a well-known acute phase reactant (4, 18, 19) . The a lAT gene is expressed in hepatocytes and mononuclear phagocytes, and these cells secrete more a lAT in response to inflammatory processes (4, 20) . To SLPI mRNA transcript levels. In the majority of studies, unless otherwise indicated, the levels of SLPI mRNA transcripts and, as a control, glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA transcripts were evaluated by Northern analysis (23) . Total cellular RNA was isolated by the guanidinium thiocyanate-CsCl gradient method (24) . RNA (10 jg/lane) was subjected to formaldehyde-agarose gel electrophoresis, transferred to a nylon membrane (Nytran; Schleicher and Schuell Inc., Keene, NH), hybridized with a 32P-labeled SLPI or GAPDH cDNA probe generated by the random priming method (25) , and quantified using a Phosphorlmager (Molecular Dynamics, Sunnyvale, CA). The SLPI probe (pPB 135) was a full-length 0.6-kb human SLPI cDNA (11) and the GAPDH probe (pPB312) was a human 1.0-kb GAPDH cDNA clone encompassing the protein coding sequence (26) .
Modulation ofSLPI gene expression in HS-24 cells. To evaluate the dose-dependency of PMA-induced modulation of SLPI gene expression, HS-24 cells were stimulated with various concentrations of PMA (0-100 nM) for 24 h. To determine the time dependence of SLPI gene expression, the cells were incubated for various times (1-48 h) in the presence of 100 nM PMA. After incubation, total cellular RNA was isolated, and the levels of SLPI mRNA transcripts and, as a control, GAPDH mRNA transcripts were evaluated by Northern analysis as described above. The mRNA levels of SLPI and GAPDH were quantified using a Phosphorlmager, and the data expressed as -fold (mean of three separate experiments) over the resting levels.
The transcription rate of the SLPI gene was examined by nuclear transcription run-on analysis (27) Inc., Friendswood, TX), purified by Sephadex G-50 column chromatography (5 Prime -3 Prime, West Chester, PA) and hybridized to excess amounts (5 jg) of DNA targets (see below) immobilized on nylon membranes. The membranes were then washed, exposed to RNase A (5 jg/ml) and RNase T. (5 U/ml), followed by proteinase K (50 jg/ ml) (all from Boehringer Mannheim, Indianapolis, IN), and evaluated by a Phosphorlmager. The DNA targets included plasmids containing a genomic clone for the SLPI gene (pPB133), an IL-8 cDNA (pPB248) and a human GAPDH cDNA (pPB312) (29) , or, as a negative control, the plasmid pUC19 (Gibco/Bethesda Research Laboratories). The relative transcription rate of the SLPI gene after PMA stimulation, compared with the resting rate, was quantified using a Phosphorlmager and expressed as -fold over the resting levels in four individual experiments.
To estimate the stability of SLPI mRNA transcripts, HS-24 cells were incubated alone or with PMA (100 nM, 12 h), and exposed to actinomycin D (5 jg/ml; Sigma Chemical Co.) for 4, 8, 12 , and 16 h (n = 4). Total cellular RNA was extracted, and SLPI mRNA levels were evaluated by Northern analysis as described above and quantified using a Phosphorlmager.
SLPI protein released by bronchial epithelial cells. To quantify the amount of SLPI protein released by the HS-24 cells, supernatants of resting and PMA-stimulated (0.1-100 nM) HS-24 cells (n = 3 at each dose) were evaluated with a specific double-antibody sandwich ELISA compared with a purified recombinant SLPI standard (9) .
Promoter activity of SLPI 5' flanking sequences. Transfection vectors containing fusion genes of 5' flanking region sequences of the SLPI gene and a luciferase reporter gene were constructed from a pUC8-derived vector (pCMV-luciferase) (30) . The SLPI promoter region, a 1,244-bp fragment spanning -1228 to +16 [numbering based on the reported sequence of SLPI gene by Abe et al. (11)], was prepared by polymerase chain reaction with plasmid pPB225 (a 1.4-kb PstI fragment containing SLPI gene exon 1 and 5' flanking region) as a template, and SLPI gene-specific primers (SLPIS5, 5 '-ATTACTCGAGCTGCAGCC-TCAAACTCCTGGGC-3'; and SLPIAS 1, 5 '-ATGTAAGCTTGG-CAGGAGTGACTCTGATGGC-3'). It was then cloned into a luciferase expression vector (pSL1228L) by replacing the cytomegalovirus (CMV) promoter in a pCMV-luciferase expression plasmid between unique XhoI and HindIII sites. Sequentially deleted fragments of the SLPI gene 5' flanking region (starting from -802, -383, -115, -97, -79, -61, and -43 to +16) were prepared in a similar manner. Based on the knowledge that the sequence between -98 and -115 may contain a cis-active element important for transcription (see Results), this sequence was deleted from the three longer constructs pSL1228L, pSL802L, and pSL383L to produce plasmids pSL1228LD, pSL802LD, and pSL383LD. This was achieved by site-directed mutagenesis using Transformer' reagents (Clontech Laboratories, Palo Alto, CA), an oligonucleotide spanning but not including the 18-bp segment (SLPI1S, 5 'CTCCTTGGTGTCAGGATTTCCCTGCTTATGCAATAGTAGC-T-3') and oligonucleotides (SLPISS for pSL1228L, 5 '-GTGCACCAT-ACATCGATCTGCAGCCTCAAAC-3'; SLPI7S for pSL802L, 5'-GTGCACCATACATCGATGCTGCITTCC-3'; SLPI9S for pSL383L, 5 '-GTGCACCATACATCGATAAGTCTCAGCAGG-3') to mutate the unique XhoI site at the 5'-end of the flanking sequences (31) . The sequences of the SLPI 5' flanking region inserts of all vectors were confirmed by the dideoxy chain-termination method (32). The Rous sarcoma virus (RSV) long terminal repeat promoter-luciferase construct (pRSVL) (33) was used as the positive control, and promoterless luciferase plasmid (pLucO) as the negative control (34) .
HS-24 cells were transfected by electroporation (35) . Cells were removed by trypsin, washed twice and resuspended in Dulbecco's phosphate-buffered saline (Gibco/Bethesda Research Laboratories) (107 cells in 0. 24 -h culture without addition of any mediators (Fig. 1 B) PMA induced HS-24 cells to increase the levels of SLPI mRNA transcripts in a dose-and time-dependent fashion (Fig.  2) . PMA-induced upregulation of SLPI gene expression was observed at low (1 nM) to high (100 nM) levels of PMA. In contrast, the level of GAPDH mRNA transcripts in the same cells did not change with increasing concentrations of PMA. After a fixed dose of PMA (100 nM) stimulation, SLPI mRNA transcript levels increased by 1 h, to its maximum at 24 h, and remained elevated at 48 h. In contrast, GAPDH mRNA transcript levels were constant during the same period.
Consistent with the increase in SLPI mRNA transcript levels, SLPI protein concentrations in the supernatants released by HS-24 cells showed a dose-dependent increase as the PMA concentrations increased (Fig. 3) . Supernatants from HS-24 cells stimulated with 100 nM PMA showed approximately twofold higher concentration of SLPI protein (19.6 ng/ml) compared with those from resting cells (10.8 ng/ml) (P < 0.05).
Evaluation of 5' transcription of the SLPI gene. Nuclear run-on analyses demonstrated that resting HS-24 cells actively transcribed the SLPI gene (Fig. 4) . After PMA stimulation, the transcription rate of the SLPI gene increased apparently twofold (P < 0.05) at 1 h and then did not change significantly for 12 h. In contrast, the transcription rate of the 11L-8 gene dramatically increased after PMA stimulation, but dramatically fell to values close to baseline by 12 h.
To evaluate possible cis-acting DNA sequences relevant to transcriptional regulation of SLPI gene expression, sequentially deleted 5' flanking region fragments of the SLPI gene were linked to a luciferase reporter gene and evaluated in HS-24 cells (Fig. 5) . This analysis demonstrated low activity until segments up to -115 bp 5' to the transcription start site were included. With increasing lengths of 5' flanking region up to -1228 bp, the relative transcription rate varied, but remained in the 10% to 17% of the RSV promoter control rate. In the context of a dramatic increase between -97 and -115, this 18 bp likely includes an important cis-control element relevant to expression of the SLPI gene. Evaluation of increasing lengths of 5' flanking sequence from -115 to -1228 showed no change in reporter gene expression (P > 0.1, all comparisons). As expected, PMA gave an overall increase in relative transcription rate with all fragments from -97 to -1,228 compared with resting values (Fig. 6) also contains a partial NFkB element, and an element resembling the serum response element (in reverse orientation) that has homology with the octomer motif, in addition to C/EBP and AP-3 sites in a region critical for PMA induction (42, 43) . Surprisingly, although important in the overall level of transcription, this 18-bp element in the SLPI 5 '-flanking region has not been shown to provide the inducibility of expression seen with PMA, as the shortest construct evaluated, pSL97, which does not include this element, and the longer constructs with this element deleted (pSL383LD, 802LD, and 1228LD) were also responsive to PMA. Stability of SLPI (Fig. 7) . There are two elements in this region of the SLPI promoter shared with the region of the Moloney murine leukemia virus (MoMLV) enhancer which confers PMA inducibility (38) . One is a partial NFkB sequence (39), also seen in the PMA response element of the urokinase gene (40) , and the other element shared with the c-fos promoter (41) and termed the serum response element. Mutation of either of these elements has been shown to markedly reduce PMA induction of transcription of the MoMLV gene (38 ( 11 ) (Fig. 8) (15) (16) (17) . The fact that the SLPI gene can be upregulated by inflammatory stimuli is of interest in the context that the synthesis of alAT, a 52-kD serine antiprotease that also plays an important role in defending the airways from NE, is also upregulated by inflammatory stimuli (4, 20) . In contrast to SLPI, which is produced by airway epithelial cells and secreted for local use, alAT is produced primarily in hepatocytes, secreted into the circulation, and diffuses across the respiratory tract to reach the epithelial surface (4, 52, 53) . alAT has long been known to be an acute phase reactant (4, 18, 19 (20, 54) . These observations, together with the knowledge that SLPI is produced by serous cells (3, 8) , while alAT is produced mainly by hepatocytes (4, 52, 53) , suggest that the two major serine antiproteases responsible for protecting the lung from NE are regulated by different mechanisms.
The 5' flanking region of SLPI gene contains elements with the potential to be modulated by inflammatory stimuli, and thus it was expected that SLPI gene expression would be influenced at the transcriptional level by PMA. The data demonstrate that this is the case, with PMA significantly upregulating the transcription of the SLPI gene in human airway epithelial cells. However, there is no apparent correlation between the known position of putative PMA response elements, including AP-I and AP-2 sites (-812, -575, and -470 for AP-1; -284 and -219 for AP-2; see reference 11), a region homologous with the PMA response element in the MoMLV promoter (-93 to -124), and the DNA fragments of the 5' flanking region responsible for the upregulation observed. The exact nature of the elements important in the upregulation of transcription of the SLPI gene by PMA remains to be defined.
Phorbol esters, including PMA, not only modulate the transcription rate of a variety of genes, but also can influence the stability of mRNA transcripts of some genes, likely through signaling mechanisms involving protein kinase C (55) (56) (57) (58) (59) (60) . Consistent with this, we observed that PMA enhanced SLPI mRNA accumulation by increasing SLPI mRNA stability. However, for most mRNA transcripts that are stabilized by PMA, such as intercellular adhesion molecule-1, granulocyte-monocyte colony stimulating factor, IL-1/3, and c-fms (57) (58) (59) (60) , the mRNAs are all short lived, and except for c-fms, the 3' untranslated regions of these mRNAs contain multiple copies of the sequence AUUUA, which serve as a destabilizing signal (57) (58) (59) (60) . This AUUUA motif and a protein that binds to the motif, adenosine-uridine binding factor, are thought to function as the cis-acting element and the trans-acting factor mediating PMAregulated turnover of these mRNAs, respectively (58, 61) . Interestingly, the SLPI mRNA does not contain this pentamer motif in the 3' untranslated region (62) , suggesting there must be other motif(s) of SLPI mRNA that confer the mRNA stabil-ity and enhance PMA-regulated stabilization of SLPI transcripts.
The airway epithelium can produce and release a variety of inflammatory mediators, including IL-1fp, IL-6, and granulocyte-macrophage colony-stimulating factor (63, 64) . Further, the airway epithelium can recruit inflammatory cells, for example by releasing 1L-8, a major chemoattractant for neutrophils (29, 65) . Importantly, as observed in the present study with the SLPI gene, the epithelium also plays an active role in defending the airways, with mechanisms regulating its defensive armamentarium against inflammation.
